Company Snapshot

Investment Thesis

Zoetis is the global leader in animal health medicines and diagnostics for livestock and companion animals. Innovation in parasiticides, vaccines, and diagnostics fuels durable double-digit growth.

  • Pet Humanization: Blockbusters like Simparica Trio and Apoquel benefit from rising pet care spend.
  • Livestock Productivity: Vaccines and anti-infectives improve herd health and farmer profitability.
  • Diagnostics Expansion: Point-of-care instruments and reference labs deliver recurring revenue.

Strategic Mix

Companion Animal Parasiticides, dermatology, pain, and diagnostics for pets
Livestock Cattle, swine, poultry, fish, and sheep therapeutics
Diagnostics & Genetics Point-of-care analyzers, reference labs, and breeding tests
Biodevices Precision livestock farming sensors and monitoring tools

Mix aligned with Zoetis’ companion vs. livestock reporting and diagnostics adjacencies.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Pipeline Strength

Monoclonal antibodies, long-acting injectables, and novel parasiticides extend leadership.

Emerging Markets

Growing middle classes in China/LatAm accelerate livestock uptake.

Digital & Data

Data platforms help veterinarians manage chronic conditions and compliance.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...